نتایج جستجو برای: oncolytic virus

تعداد نتایج: 399332  

2017
Lili Deng Jun Fan Yuedi Ding Jue Zhang Bin Zhou Yi Zhang Biao Huang

Oncolytic virotherapy is being developed as a promising platform for cancer therapy due to its ability to lyse cancer cells in a tumor-specific manner. Vaccinia virus has been used as a live vaccine in the smallpox eradication program and now is being potential in cancer therapy with a great safety profile. Vaccinia strain Guang9 (VG9) is an attenuated Chinese vaccinia virus and its oncolytic e...

2016
Autumn J. Ruiz Elizabeth M. Hadac Rebecca A. Nace Stephen J. Russell

UNLABELLED Mengovirus, a member of thePicornaviridaefamily, has a broad cell tropism and can cause encephalitis and myocarditis in multiple mammalian species. Attenuation has been achieved by shortening the polycytidine tract in the 5' noncoding region (NCR). A poly(C)-truncated strain of mengovirus, vMC24, resulted in significant tumor regression in immunocompetent BALB/c mice bearing syngenei...

Journal: :Molecular therapy : the journal of the American Society of Gene Therapy 2011
Vincenzo Cerullo Iulia Diaconu Lotta Kangasniemi Maria Rajecki Sophie Escutenaire Anniina Koski Valentina Romano Noora Rouvinen Tamara Tuuminen Leena Laasonen Kaarina Partanen Satu Kauppinen Timo Joensuu Minna Oksanen Sirkka-Liisa Holm Elina Haavisto Aila Karioja-Kallio Anna Kanerva Sari Pesonen Petteri T Arstila Akseli Hemminki

Patients with advanced solid tumors refractory to and progressing after conventional therapies were treated with three different regimens of low-dose cyclophosphamide (CP) in combination with oncolytic adenovirus. CP was given with oral metronomic dosing (50 mg/day, N = 21), intravenously (single 1,000 mg dose, N = 7) or both (N = 7). Virus was injected intratumorally. Controls (N = 8) received...

Journal: :Neuro-oncology 2022

Abstract Oncolytic virotherapy shows great potential for treating brain tumors and other solid that metastasize to the brain. A phase I clinical trial testing oncolytic adenovirus Delta-24-RGD (DNX-2401) in patients with recurrent malignant gliomas demonstrated significant benefits a subset of patients, another pediatric also indicated similar benefits. However, virus injection initiates both a...

2017
Michael Karl Melzer Arturo Lopez-Martinez Jennifer Altomonte

Oncolytic viruses have gained much attention in recent years, due, not only to their ability to selectively replicate in and lyse tumor cells, but to their potential to stimulate antitumor immune responses directed against the tumor. Vesicular stomatitis virus (VSV), a negative-strand RNA virus, is under intense development as an oncolytic virus due to a variety of favorable properties, includi...

Journal: :Journal of the Royal Society, Interface 2009
Dominik Wodarz

Targeted therapy using small-molecule inhibitors is a promising new therapy approach against cancer, but drug-resistant mutants present an obstacle to success. Oncolytic virus therapy, where viruses replicate specifically in cancer cells and kill them, is another promising therapy approach against cancer. While encouraging results have been observed in clinical trials, consistent success has no...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Shanthi Ganesh Melissa Gonzalez-Edick Douglas Gibbons Melinda Van Roey Karin Jooss

PURPOSE Evaluate the codelivery of hyaluronidase enzyme with oncolytic adenoviruses to determine whether it improves the spread of the virus throughout tumors, thereby leading to a greater overall antitumor efficacy in tumor models. EXPERIMENTAL DESIGN The optimal dose of hyaluronidase that provided best transduction efficiency and spread of a green fluorescent protein (GFP)-expressing adenov...

2014
Jennifer Altomonte Oliver Ebert

Oncolytic viral therapies have recently found their way into clinical application for hepatocellular carcinoma (HCC), a disease with limited treatment options and poor prognosis. Adding to the many intrinsic challenges of in vivo oncolytic viral therapy, is the complex microenvironment of the liver, which imposes unique limitations to the successful delivery and propagation of the virus. The no...

Journal: :Human gene therapy 2005
Alexander N Lukashev Christophe Fuerer Ming-Jen Chen Peter Searle Richard Iggo

We have constructed an oncolytic adenovirus expressing the Escherichia coli nitroreductase gene nfsB from an internal ribosome entry site (IRES) in the adenovirus L5 major late transcript. The virus (Tcf-NTR) has Tcf transcription factor-binding sites in the E1A, E1B, and E4 promoters, which restrict viral replication to cells that have activation of the Wnt signaling pathway. This virus was co...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Jay D Naik Christopher J Twelves Peter J Selby Richard G Vile John D Chester

Oncolytic viruses consist of a diverse range of DNA and RNA viruses traditionally thought to mediate their effects by exploiting aberrations in tumor pathways, allowing preferential viral replication in, and killing of, tumor cells. Clinical development has progressed to late-phase trials, potentially heralding their introduction into clinical practice. However, despite this promise, the activi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید